Decent write-up, probably one of the better, more balanced
Decent write-up, probably one of the better, more balanced articles that’s been written over the past couple months. Not much pump, which I like, and just the right amount of facts.
One question for all: Did NP allude to this statement fringe article in the CC last week?
“The CEO stated that they have finalized a deal with a Chinese partner and are awaiting approval to release the news.”
NP said they signed an NBA with the company and that is will take some time to compete. I don’t recall him saying they finalized a deal and that announcing the deal hinged on approval (approval of what? Leronlimab in China?). I think the author interpreted the CC differently than me and I think the section below is what that interpretation is based on.
27:10 very very confident about okay second
27:14 question is when do you expect to
27:15 finalize the agreement with the Chinese
27:18 partner and whether there will be a
27:21 front payment yes we will be making a
27:25 press release about that as soon as we
27:27 have you know everybody's buying so
27:29 everybody can understand who their
27:31 company is and what they're doing how
27:34 large though with the scale they are and
27:36 all of those will be announced in a
27:38 press release and any agreement that is
27:41 finalized which will take some time
To me, NP is saying here that they signed an NBA and that the deal will be announced once all the details are hammered out, which could take time. And I don’t think details of the NBA are going to be PRed, only the finalized deal.
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...
Continue Reading
Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...
Continue Reading
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...
Continue Reading
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Top 5 Most Recently Viewed Articles
A Fresh Perspective on Auto Loan Preapproval Diving into the maze of auto financing, sometimes you gotta stop and smell the coffee—that's where this HelloNation piece comes in, serving a dose of clarity for potential car buyers. Brad Bailey, the top dog at Red River Credit Union, steps into the fray to break it down. Gaining Financial Insight Ahead of the Game Think of...
Continue Reading
ArcelorMittal's Commitment to Decarbonization ArcelorMittal is on a transformative journey to reshape its decarbonization strategy in Europe. The company has laid out a roadmap that prioritizes the replacement of traditional blast furnaces with lower carbon emissions facilities, specifically hydrogen-ready DRI-EAF systems. This endeavor marks a pivotal step forward in...
Continue Reading
Can International Stocks Surpass U.S. Performance? According to recent insights from a Vanguard economist, the landscape for stock investments is shifting, suggesting that international markets might finally outpace U.S. stocks. After facing challenges early in the year, U.S. stocks have rebounded impressively. The S&P 500 index has increased by approximately 16%...
Continue Reading
MellingMedical Receives Federal Supply Schedule Contract MellingMedical proudly announces its successful acquisition of a federal contract specifically designed for essential pharmaceuticals. This new agreement plays a pivotal role in ensuring America's veterans have timely access to critical medications and health products. Understanding the Federal Supply Schedule The...
Continue Reading
A Heavyweight Joins the Global Battery Materials Camp This isn't your run-of-the-mill executive shuffle, folks. Global Battery Materials Corp. (GBM) has just brought in a marksman in the battery world—Dr. Yi Hyon Paik. The guy doesn't just dabble; he's chalked up over 30 years in the trenches of battery technology, electronic materials, and the big leagues of energy...
Continue Reading